ZIM
BLFS icon

Zacks Investment Management’s BioLife Solutions BLFS Stock Holding History

Zacks Investment Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Sell
67,506
-2,966
-4% -$69.3K 0.01% 370
2026
Q1 		$1.34M Buy
70,472
+1,156
+2% +$25.6K 0.01% 385
2025
Q4 		$1.68M Buy
69,316
+86
+0.1% +$2.25K 0.01% 371
2025
Q3 		$1.77M Buy
69,230
+4,246
+7% +$101K 0.01% 348
2025
Q2 		$1.4M Buy
+64,984
New +$1.46M 0.01% 363

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Zacks Investment Management's BLFS Position: Q2 2026 in Review

Zacks Investment Management reduced its BioLife Solutions (BLFS) stake by 4.2% in Q2 2026, selling an estimated $69.3K and leaving 67,506 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #370.

Zacks Investment Management first reported a position in BLFS in Q2 2025 and has held it in 5 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Zacks Investment Management held 67,506 shares of BioLife Solutions worth $1.91M as of Q2 2026.
  • Zacks Investment Management sold 2,966 BioLife Solutions shares in Q2 2026, an estimated $69.3K.
  • BioLife Solutions made up 0.01% of Zacks Investment Management's portfolio in Q2 2026, its #370 holding.
  • Zacks Investment Management first reported a position in BioLife Solutions in Q2 2025 and has held it in 5 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.